Synthesis, Activity, and Application of Fluorescent Analogs of [D1G, 14Q]LvIC Targeting 6?4 Nicotinic Acetylcholine Receptor
Shengrong Pei,Chenxing Xu,Yao Tan,Meiting Wang,Jinpeng Yu,Dongting Zhangsun,Xiaopeng Zhu,Sulan Luo
DOI: https://doi.org/10.1021/acs.bioconjchem.3c00283
IF: 4.7
2023-01-01
Bioconjugate Chemistry
Abstract:alpha 6 ss 4(*) nicotinic acetylcholine receptor (nAChR) (* represents the possible presence of additional subunits) is mainly distributed in the central and peripheral nervous system and is associated with neurological diseases, such as neuropathic pain; however, the ability to explore its function and distribution is limited due to the lack of pharmacological tools. As one of the analogs of alpha-conotoxin (alpha-CTx) LvIC from Conus lividus, [D1G,.14Q]LvIC (Lv) selectively and potently blocks alpha 6/alpha 3 ss 4 nAChR (alpha 6/alpha 3 represents a chimera). Here, we synthesized three fluorescent analogs of Lv by connecting fluorescent molecules 6carboxytetramethylrhodamine succinimidyl ester (6-TAMRA-SE, R), Cy3 NHS ester (Cy3, C) and BODIPY-FL NHS ester (BDP, B) to the N-terminus of the peptide and obtained Lv-R, Lv-C, and Lv-B, respectively. The potency and selectivity of three fluorescent peptides were evaluated using two-electrode voltage-clamp recording on nAChR subtypes expressed in Xenopus laevis oocytes, and the potency and selectivity of Lv-B were almost maintained with the half-maximal inhibition (IC50) of 64 nM. Then, we explored the stability of Lv-B in artificial cerebrospinal fluid and stained rat brain slices with Lv-B. The results indicated that the stability of Lv-B was slightly improved compared to that of native Lv. Additionally, we detected the distribution of the alpha 6 ss 4* nAChR subtype in the cerebral cortex using green fluorescently labeled peptide and fluorescence microscopy. Our findings not only provide a visualized pharmacological tool for exploring the distribution of the alpha 6 ss 4* nAChR subtype in various situ tissues and organs but also extend the application of alpha-CTx [D1G, Delta 14Q]LvIC to demonstrate the involvement of alpha 6 ss 4 nAChR function in pathophysiology and pharmacology.